These include wild-type and structurally stabilized variants, such as ΔF508, G551D, E1371Q and H1402S, each in a stabilized background. See Table 1 for additional information. Core Function #2: ...
Despite entering its maturation phase, the recombinant protein sector will continue to drive the growth of medical biotechnology over the next six years. You have full access to this article via ...
tebu-bio offers recombinant protein production services using a robust, inexpensive and fast transient-expression system in Chinese hamster ovary (CHO) cells, for various research and development ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback